This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The National Wastewater Surveillance System’s funding expires at the end of fisc...
Bill Nye critiqued HHS chief Robert F. Kennedy Jr. and his views on science and ...
At the STAT Summit on Thursday, researchers called for a "full-throated defense"...
Ozempic might feature in future US negotiations with Denmark over Greenland
DNA sequencing specialist’s decision to list in London in 2021 was seen as a vic...
Experts say there are regional disparities in medication access even as prescrip...
Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology com...
SYDNEY, Australia, 19 March 2025: Imugene Limited (ASX:IMU), a clinical-stage im...
The FDA approved Tremfya as an induction therapy in adults with moderately to se...
Novartis is laying off 427 employees who report to its headquarters in East Hano...
Despite growing competition in the transthyretin amyloid cardiomyopathy (ATTR-CM...
THURSDAY, March 20, 2025 -- In an effort to guarantee "the ongoing quality, saf...
THURSDAY, March 20, 2025 -- The total injury death rate in the United States in...
THURSDAY, March 20, 2025 -- Increasing sleepiness is associated with increased ...
Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday abo...
The FDA cleared Alnylam’s therapy for the heart disease ATTR-CM, setting the com...
Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a ...
“It’s like we're in a toxic relationship with our employer”: Fired probationary ...
Trump's former FDA commissioner criticized the current administration's approach...
This week on "The Readout LOUD" podcast: Zealand's obesity strategy, Immunovant'...
Expedition Therapeutics, a new startup hoping to source the best therapies being...
Hollywood has in recent years been undergoing a much-needed, long-awaited transf...
Global pharma giants AstraZeneca, Bristol Myers Squibb, Johnson & Johnson, Novar...
BioNTech has passed on Autolus Therapeutics’ dual targeting CAR-T cell therapy. ...